Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
374 GBX | -0.27% | +1.91% | +6.10% |
22/05 | MaxCyte inks deal with Legend Biotech for tech supply | AN |
22/05 | MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.10% | 48Cr | |
+4.34% | 22TCr | |
+8.39% | 19TCr | |
+20.14% | 14TCr | |
+30.12% | 11TCr | |
+1.86% | 6.48TCr | |
+15.38% | 5.24TCr | |
+3.01% | 4.99TCr | |
-4.93% | 4.26TCr | |
-0.36% | 3.58TCr |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MaxCyte Shares Rise Sharply After Q1 Results Beat